Health In Tech, Inc. (NASDAQ:HIT – Free Report) – Research analysts at Maxim Group lowered their Q3 2026 earnings per share estimates for Health In Tech in a note issued to investors on Friday, October 2nd. Maxim Group analyst A. Klee now forecasts that the company will post earnings per share of ($0.10) for the quarter, down from their prior estimate of ($0.04). Maxim Group currently has a “Buy” rating and a $3.00 price target on the stock. Maxim Group also issued estimates for Health In Tech’s Q4 2026 earnings at ($0.14) EPS, FY2026 earnings at ($0.31) EPS, Q1 2027 earnings at ($0.05) EPS, Q2 2027 earnings at ($0.06) EPS, Q3 2027 earnings at ($0.06) EPS, Q4 2027 earnings at ($0.09) EPS and FY2027 earnings at ($0.26) EPS.
Health In Tech (NASDAQ:HIT – Get Free Report) last released its earnings results on Thursday, August 13th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.01). The business had revenue of $8.06 million during the quarter.
Check Out Our Latest Analysis on HIT
Health In Tech Stock Down 2.4%
Shares of HIT opened at $0.80 on Tuesday. The stock has a market capitalization of $52.43 million, a P/E ratio of -11.43 and a beta of 2.81. Health In Tech has a twelve month low of $0.65 and a twelve month high of $4.02. The company has a 50 day moving average of $0.96 and a 200-day moving average of $1.14.
Institutional Trading of Health In Tech
An institutional investor recently bought a new position in Health In Tech stock. Whetstone Capital Advisors LLC purchased a new stake in shares of Health In Tech, Inc. (NASDAQ:HIT – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,509,766 shares of the company’s stock, valued at approximately $1,525,000. Whetstone Capital Advisors LLC owned about 2.30% of Health In Tech as of its most recent filing with the Securities and Exchange Commission (SEC).
Health In Tech News Roundup
Here are the key news stories impacting Health In Tech this week:
- Positive Sentiment: Maxim Group maintained its Buy rating and $3.00 price objective, implying substantial potential upside if Health In Tech can meet longer-term operating expectations. Health In Tech Q3 Earnings Forecast Decreased by Maxim Group
- Neutral Sentiment: Maxim forecast 2027 quarterly losses of $0.05 to $0.09 per share and a full-year loss of $0.26 per share, including a $0.06-per-share loss estimate for the third quarter.
- Negative Sentiment: Maxim cut its Q3 2026 EPS estimate to a $0.10 loss from a $0.04 loss, Q4 2026 to a $0.14 loss from $0.03, and full-year 2026 to a $0.31 loss from $0.10.
- Negative Sentiment: The analyst also reduced its Q1 2027 estimate to a $0.05 loss from $0.01 earnings, Q2 2027 to a $0.06 loss from a $0.01 loss, and full-year 2027 to a $0.26 loss from $0.02 earnings. These downward revisions suggest profitability may take longer to achieve.
- Negative Sentiment: The company’s latest reported quarter already showed a $0.04-per-share loss, missing the $0.03 loss expected by analysts, which may reinforce concerns about near-term execution and financial performance.
Health In Tech Company Profile
Health In Tech, Inc is a United States-based insurance technology company that provides a digital platform for the self-funded health benefits market. Its technology is designed to connect employers, insurance brokers, third-party administrators, and insurance carriers through a streamlined process for evaluating, selecting, and administering health benefit plans.
The company’s platform supports activities such as plan quoting, proposal management, enrollment, benefits administration, and ongoing communication among participants in the insurance process.
Featured Articles
- Five stocks we like better than Health In Tech
- Constellation Energy’s Google Deal Shows Why Nuclear Uprates Matter for AI
- Lamb Weston’s Turnaround Is Starting to Look Real
- These 3 Stocks Got the Most Love From Analysts in September
- Record French Debt Could Create Opportunities for U.S. Market Operators
Receive News & Ratings for Health In Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health In Tech and related companies with MarketBeat.com's FREE daily email newsletter.
